We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA3:BMFBOVESPAAXIA Energia SA Analysis

Data as of 2026-08-27 - not real-time

R$53.41

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At BRL 53.41, AXIA Energia SA shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it gained 5.9%. Momentum indicators put RSI at 59.0 (neutral) with MACD reading bullish. Watch BRL 48.64 as support and BRL 55.09 as the nearer resistance level.
The shares look undervalued, trading on 10.2 times earnings below a sector average of 19.8. Consensus targets land 31.2% above where the shares trade now. Revenue is growing at 9.7% on a 27.1% profit margin. The 6.83% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 26.9%, a beta of 0.58 and a maximum drawdown of 27.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 6/10 conviction over the longer horizon.

Top Market Events

Seeking Alpha20dAXIA Energia SA AXIA Q2 2026 Earnings Call TranscriptGood morning, ladies and gentlemen.Detailed price information for Axia Energia ADR AXIA-N from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 56.50
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 10.2 versus sector average of 19.8
  • Trading below the 200-day average of 56.50

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.2 versus sector average of 19.8
  • Analyst targets imply +31.2% versus the current price
  • Profit margin of 27.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin27.05%
P/E Ratio10.2
ROE10.01%
ROA3.03%
Debt/Equity62.52
P/B Ratio1.3
Op. Cash FlowR$16.7B
Free Cash FlowR$1.3B
Industry P/E19.8

Technical Analysis

TrendBearish
RSI59.0
SupportR$48.64
ResistanceR$55.09
MA 20R$51.86
MA 50R$52.28
MA 200R$56.50
MACDBullish
VolumeDecreasing
Fear & Greed Index94.68

Valuation

Target PriceR$70.08
Upside/Downside31.20%
GradeUndervalued
TypeValue
Dividend Yield6.83%

Risk Assessment

Beta0.58
Volatility26.92%
Sector RiskLow
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.